Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2026Cancer Research

Synergistic Effects of CDK4/6 Inhibitor, TMZ, and Radiation in DIPG Models

View Full Paper
Ask AI
Bookmark
Share

Authors

ZHZilu HuangTJTongchao JiangMPMilagros M. Suarez Palacios

Discussion

Loading...

Member takes

Overview

Combination therapy improves survival in DIPG models, suggesting new treatment targets for resistance.

Key Points

  • To evaluate the efficacy and mechanisms of a triple therapy combining abemaciclib, TMZ, and radiation in treating DIPG.
  • Investigated anti-tumor activities in tumor organoids.
  • Applied combination treatment in PDOX models with specified dosing.
  • Analyzed survival times using log-rank analysis.
  • Utilized immunohistochemistry and scRNA-seq to explore treatment responses.
  • Triple therapy significantly enhanced survival times in both PDOX models (P<0.05).
  • Identified changes in cellular states linked to treatment response and resistance.
  • Reduced OPC-like cells and identified resistance mechanisms in IBs-9119DIPG.
  • Discovered potential radiation-resistant targets including NPAS3 and TBC1D5.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd29a79560c99a0a301ahttps://doi.org/10.1158/1538-7445.am2026-1150
View Full Paper
Ask AI
Bookmark
Share